Long-term, prolonged-release tacrolimus-based immunosuppression in de novo kidney transplant recipients: 5-year prospective follow-up of the ADHERE study patients

O. Rummo, M. Carmellini, N. Kamar, A. Durrbach, C. Mousson, F. Caputo, Z. Mathe, M.H.L. Christiaans, D.R.J. Kuypers, U.J. Klempna, S. Anaokar, M. Hurst, G. Kazeem, N. Undre, F. Lehner

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)161-173
Number of pages13
JournalTransplant International
Volume33
Issue number2
DOIs
Publication statusPublished - 1 Feb 2020

Keywords

  • adverse drug-reactions
  • daily prograf
  • formulation
  • immunosuppression
  • kidney
  • kidney transplant
  • observational
  • prolonged-release tacrolimus
  • renal-transplantation
  • transplant
  • twice-daily tacrolimus
  • TWICE-DAILY TACROLIMUS
  • RENAL-TRANSPLANTATION
  • ADVERSE DRUG-REACTIONS
  • FORMULATION
  • DAILY PROGRAF

Cite this